The pathogenesis of LAM is related to mutations in the TSC1/TSC2 genes, which lead to over-activation of the mTOR pathway, the target protein of rapamycin, and thus regulate the growth of LAM cells. The gene discussed is TSC2; the disease is lymphangioleiomyomatosis.